Table: Hisamitsu -2021/22 group results

Hisamitsu Pharmaceutical Co

07/04/2022 07:00

Apr 7 (Reuters)- 
          Hisamitsu Pharmaceutical Co Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                Feb 28, 2022    Feb 28, 2021   Feb 28, 2023     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales            120.19          114.51         123.00                 
                 (+5.0 pct)      (-18.8 pct)    (+2.3 pct)               
  Operating          9.34           10.67          11.10                 
                 (-12.5 pct)     (-53.0 pct)    (+18.9 pct)              
  Recurring         12.64           11.83          12.70                 
                 (+6.8 pct)      (-53.8 pct)    (+0.5 pct)               
  Net
  Net                9.66            9.25           9.70                 
                 (+4.4 pct)      (-50.5 pct)    (+0.4 pct)               
  EPS            118.92 yen      113.22 yen     119.44 yen               
  EPS Diluted    118.84 yen      113.11 yen                              
  Ann Div         84.00 yen       83.50 yen      84.50 yen               
  -Q2 Div         42.00 yen       41.75 yen      42.25 yen               
  -Q4 Div         42.00 yen       41.75 yen      42.25 yen               
  
  NOTE - Hisamitsu Pharmaceutical Co Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T